Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for NK 1) receptor
Most Correlated Studies
- T-ALL KHYG1 control or DOCK8 knockout cells activated with anti-NKp30
- T cell chronic lymphocytic leukemia Kit 225 cell responses to interleukin-2
- PBMCs of adult T-cell leukemia/lymphoma (ATLL) patients treated with either IFN-a or IFN-b
- L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
- Cutaneous T-Cell lymphoma HuT78 cell line treated with AR-A014418 and/or Enzastaurin
Most Relevant Literature
- Neurokinin 1 Receptor Antagonists for Pruritus.
- The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target fo…
- Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multif…
- Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneed…
- Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment.
Most Relevant Clinical Trials
- Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagon…
- NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
- Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies
- NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
- Personalized NK Cell Therapy in CBT
